Abstract
It is not uncommon for the ophthalmologist to be the first to diagnose neurological pathology. Some of these conditions will be amenable to catheter-based neurointervention. Among these conditions, cerebral aneurysms and carotid-cavernous fistulas are the two most common conditions. Idiopathic intracranial hypertension is another disease that may be amenable to neurointerventional treatment, although its role remains controversial. Cerebral aneurysms have been described in previous chapters (see Chaps. 10 and 11) and only the ophthalmologic manifestations are described here. The remainder of the chapter will focus on the anatomy, clinical presentation, imaging characteristics, and management of the carotid-cavernous fistula and idiopathic intracranial hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schievink WI. Intracranial aneurysms. N Engl J Med. 1997;336:28–40.
Agarwal N, Gala NB, Choudhry OJ, et al. Prevalence of asymptomatic incidental aneurysms: a review of 2685 computed tomographic angiograms. World Neurosurg. 2013.
Inagawa T, Hirano A. Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol. 1990;34:361–5.
Sugar O. Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol. 1992; 37:158.
Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg. 2000;93:379–87.
Loumiotis I, Wagenbach A, Brown Jr RD, Lanzino G. Small (<10-mm) incidentally found intracranial aneurysms, Part 1: reasons for detection, demographics, location, and risk factors in 212 consecutive patients. Neurosurg Focus. 2011;31:E3.
Lawson MF, Neal DW, Mocco J, Hoh BL. Rationale for treating unruptured intracranial aneurysms: actuarial analysis of natural history risk versus treatment risk for coiling or clipping based on 14,050 patients in the Nationwide Inpatient Sample database. World Neurosurg. 2013;79:472–8.
Biousse V, Mendicino ME, Simon DJ, Newman NJ. The ophthalmology of intracranial vascular abnormalities. Am J Ophthalmol. 1998;125:527–44.
Liu GV, Volpe NL, Galetta SL. Neuro-ophthalmology diagnosis and management. 2nd ed. New York: Saunders Elsevier; 2010.
Dailey EJ, Holloway JA, Murto RE, Schlezinger NS. Evaluation of ocular signs and symptoms in cerebral aneurysms. Arch Ophthalmol. 1964;71:463–74.
Yang HS, Joe SG, Yoon YH, Kim JG. A case of Purtscher retinopathy associated with stent-assisted coil embolization of a middle cerebral artery aneurysm. Eur J Ophthalmol. 2013; 23:262–6.
Takahashi Y, Kakizaki H, Selva D, Leibovitch I. Bilateral orbital compartment syndrome and blindness after cerebral aneurysm repair surgery. Ophthal Plast Reconstr Surg. 2010;26: 299–301.
Jacob JT, Burns JA, Dupont SA, Lanzino G, Wijdicks EF. Wall-eyed bilateral internuclear ophthalmoplegia after ruptured aneurysm. Arch Neurol. 2010;67:636–7.
Garfinkle AM, Danys IR, Nicolle DA, Colohan AR, Brem S. Terson’s syndrome: a reversible cause of blindness following subarachnoid hemorrhage. J Neurosurg. 1992;76:766–71.
Schultz PN, Sobol WM, Weingeist TA. Long-term visual outcome in Terson syndrome. Ophthalmology. 1991;98:1814–9.
Loumiotis I, Brown Jr RD, Vine R, Cloft HJ, Kallmes DF, Lanzino G. Small (<10-mm) incidentally found intracranial aneurysms, Part 2: treatment recommendations, natural history, complications, and short-term outcome in 212 consecutive patients. Neurosurg Focus. 2011;31:E4.
Wiebers DO, Whisnant JP, Huston 3rd J, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003; 362:103–10.
McKinna AJ. Eye signs in 611 cases of posterior fossa aneurysms: their diagnostic and prognostic value. Can J Ophthalmol. 1983;18:3–6.
Hamer J. Prognosis of oculomotor palsy in patients with aneurysms of the posterior communicating artery. Acta Neurochir. 1982;66:173–85.
Blumenfeld H. Brainstem II: eye movements and pupillary control. In: Neuroanatomy through clinical cases. 2. Sunderland, MA: Sinauer; 2002.
Miller NR. Diagnosis and management of dural carotid-cavernous sinus fistulas. Neurosurg Focus. 2007;23:E13.
Brosnahan D, McFadzean RM, Teasdale E. Neuro-ophthalmic features of carotid cavernous fistulas and their treatment by endoarterial balloon embolisation. J Neurol Neurosurg Psychiatry. 1992;55:553–6.
Gupta AK, Purkayastha S, Krishnamoorthy T, et al. Endovascular treatment of direct carotid cavernous fistulae: a pictorial review. Neuroradiology. 2006;48:831–9.
Henderson JW, Schneider RC. The ocular findings in carotid-cavernous fistula in a series of 17 cases. Am J Ophthalmol. 1959;48:585–97.
Kobayashi N, Miyachi S, Negoro M, et al. Endovascular treatment strategy for direct carotid-cavernous fistulas resulting from rupture of intracavernous carotid aneurysms. AJNR Am J Neuroradiol. 2003;24:1789–96.
Kupersmith MJ, Berenstein A, Choi IS, Warren F, Flamm E. Management of nontraumatic vascular shunts involving the cavernous sinus. Ophthalmology. 1988;95:121–30.
Halbach VV, Higashida RT, Hieshima GB, Reicher M, Norman D, Newton TH. Dural fistulas involving the cavernous sinus: results of treatment in 30 patients. Radiology. 1987;163: 437–42.
Phelps CD, Thompson HS, Ossoinig KC. The diagnosis and prognosis of atypical carotid-cavernous fistula (red-eyed shunt syndrome). Am J Ophthalmol. 1982;93:423–36.
Sanders MD, Hoyt WF. Hypoxic ocular sequelae of carotid-cavernous fistulae. Study of the causes of visual failure before and after neurosurgical treatment in a series of 25 cases. Br J Ophthalmol. 1969;53:82–97.
Goldberg RA, Goldey SH, Duckwiler G, Vinuela F. Management of cavernous sinus-dural fistulas. Indications and techniques for primary embolization via the superior ophthalmic vein. Arch Ophthalmol. 1996;114:707–14.
Palestine AG, Younge BR, Piepgras DG. Visual prognosis in carotid-cavernous fistula. Arch Ophthalmol. 1981;99:1600–3.
Annesley-Williams DJ, Goddard AJ, Brennan RP, Gholkar A. Endovascular approach to treatment of indirect carotico-cavernous fistulae. Br J Neurosurg. 2001;15:228–33.
Barry RC, Wilkinson M, Ahmed RM, et al. Interventional treatment of carotid cavernous fistula. J Clin Neurosci. 2011;18:1072–9.
Chen ZQ, Deng DF, Gu BX, et al. [Treatment of dural arteriovenous fistula by transarterial embolization with low dose of N-butyl-2-cyanoacrylate]. Zhonghua yi xue za zhi. 2006; 86:157–9.
Jung KH, Kwon BJ, Chu K, et al. Clinical and angiographic factors related to the prognosis of cavernous sinus dural arteriovenous fistula. Neuroradiology. 2011;53:983–92.
Kai Y, Hamada J, Morioka M, Yano S, Kuratsu J. Treatment of cavernous sinus dural arteriovenous fistulae by external manual carotid compression. Neurosurgery. 2007;60:253–7. Discussion 257–8.
Keltner JL, Satterfield D, Dublin AB, Lee BC. Dural and carotid cavernous sinus fistulas. Diagnosis, management, and complications. Ophthalmology. 1987;94:1585–600.
Kirsch M, Henkes H, Liebig T, et al. Endovascular management of dural carotid-cavernous sinus fistulas in 141 patients. Neuroradiology. 2006;48:486–90.
Liu HM, Wang YH, Chen YF, Cheng JS, Yip PK, Tu YK. Long-term clinical outcome of spontaneous carotid cavernous sinus fistulae supplied by dural branches of the internal carotid artery. Neuroradiology. 2001;43:1007–14.
Luo CB, Teng MM, Chang FC, Chang CY. Traumatic indirect carotid cavernous fistulas: angioarchitectures and results of transarterial embolization by liquid adhesives in 11 patients. Surg Neurol. 2009;71:216–22.
Meyers PM, Halbach VV, Dowd CF, et al. Dural carotid cavernous fistula: definitive endovascular management and long-term follow-up. Am J Ophthalmol. 2002;134:85–92.
Miller NR, Monsein LH, Debrun GM, Tamargo RJ, Nauta HJ. Treatment of carotid-cavernous sinus fistulas using a superior ophthalmic vein approach. J Neurosurg. 1995;83:838–42.
Oishi H, Arai H, Sato K, Iizuka Y. Complications associated with transvenous embolisation of cavernous dural arteriovenous fistula. Acta Neurochir. 1999;141:1265–71.
Preechawat P, Narmkerd P, Jiarakongmun P, Poonyathalang A, Pongpech SM. Dural carotid cavernous sinus fistula: ocular characteristics, endovascular management and clinical outcome. J Med Assoc Thai. 2008;91:852–8.
Quinones D, Duckwiler G, Gobin PY, Goldberg RA, Vinuela F. Embolization of dural cavernous fistulas via superior ophthalmic vein approach. AJNR Am J Neuroradiol. 1997;18:921–8.
Yoshida K, Melake M, Oishi H, Yamamoto M, Arai H. Transvenous embolization of dural carotid cavernous fistulas: a series of 44 consecutive patients. AJNR Am J Neuroradiol. 2010;31:651–5.
Yu SC, Cheng HK, Wong GK, Chan CM, Cheung JY, Poon WS. Transvenous embolization of dural carotid-cavernous fistulae with transfacial catheterization through the superior ophthalmic vein. Neurosurgery. 2007;60:1032–7. Discussion 1037–8.
Hawke SH, Mullie MA, Hoyt WF, Hallinan JM, Halmagyi GM. Painful oculomotor nerve palsy due to dural-cavernous sinus shunt. Arch Neurol. 1989;46:1252–5.
Miller NR. Dural carotid-cavernous fistulas: epidemiology, clinical presentation, and management. Neurosurg Clin N Am. 2012;23:179–92.
Selky AK, Purvin VA. Isolated trochlear nerve palsy secondary to dural carotid-cavernous sinus fistula. J Neuroophthalmol. 1994;14:52–4.
Sempere AP, Menendez BM, Alvarez CC, Hoenigsfeld LC. Isolated oculomotor nerve palsy due to dural cavernous sinus fistula. Eur Neurol. 1991;31:2.
Stiebel-Kalish H, Setton A, Berenstein A, Kalish Y, Nimii Y, Kupersmith MJ. Bilateral orbital signs predict cortical venous drainage in cavernous sinus dural AVMs. Neurology. 2002;58:1521–4.
Chaudhry IA, Elkhamry SM, Al-Rashed W, Bosley TM. Carotid cavernous fistula: ophthalmological implications. Middle East Afr J Ophthalmol. 2009;16:57–63.
Rucker JC, Biousse V, Newman NJ. Magnetic resonance angiography source images in carotid cavernous fistulas. Br J Ophthalmol. 2004;88:311.
Spector RH. Echographic diagnosis of dural carotid-cavernous sinus fistulas. Am J Ophthalmol. 1991;111:77–83.
Haugen OH, Sletteberg O, Thomassen L, Krakenes J. Bilateral non-traumatic carotid cavernous sinus fistula with spontaneous closure. Acta Ophthalmol. 1990;68:743–7.
Higashida RT, Hieshima GB, Halbach VV, Bentson JR, Goto K. Closure of carotid cavernous sinus fistulae by external compression of the carotid artery and jugular vein. Acta Radiol Suppl. 1986;369:580–3.
Barrow DL, Spector RH, Braun IF, Landman JA, Tindall SC, Tindall GT. Classification and treatment of spontaneous carotid-cavernous sinus fistulas. J Neurosurg. 1985;62:248–56.
Miyamoto N, Naito I, Takatama S, Shimizu T, Iwai T, Shimaguchi H. Clinical and angiographic characteristics of cavernous sinus dural arteriovenous fistulas manifesting as venous infarction and/or intracranial hemorrhage. Neuroradiology. 2009;51:53–60.
Gemmete JJ, Chaudhary N, Pandey A, Ansari S. Treatment of carotid cavernous fistulas. Curr Treat Options Neurol. 2010;12:43–53.
Wolfe SQ, Cumberbatch NM, Aziz-Sultan MA, Tummala R, Morcos JJ. Operative approach via the superior ophthalmic vein for the endovascular treatment of carotid cavernous fistulas that fail traditional endovascular access. Neurosurgery. 2010;66:293–9. Discussion 299.
Sergott RC, Grossman RI, Savino PJ, Bosley TM, Schatz NJ. The syndrome of paradoxical worsening of dural-cavernous sinus arteriovenous malformations. Ophthalmology. 1987;94:205–12.
Barcia-Salorio JL, Soler F, Barcia JA, Hernandez G. Stereotactic radiosurgery for the treatment of low-flow carotid-cavernous fistulae: results in a series of 25 cases. Stereotact Funct Neurosurg. 1994;63:266–70.
Tiewei Q, Ali A, Shaolei G, et al. Carotid cavernous fistulas treated by endovascular covered stent grafts with follow-up results. Br J Neurosurg. 2010;24:435–40.
Bruce BB, Biousse V, Newman NJ. Update on idiopathic intracranial hypertension. Am J Ophthalmol. 2011;152:163–9.
Bruce BB, Preechawat P, Newman NJ, Lynn MJ, Biousse V. Racial differences in idiopathic intracranial hypertension. Neurology. 2008;70:861–7.
Dessardo NS, Dessardo S, Sasso A, Sarunic AV, Dezulovic MS. Pediatric idiopathic intracranial hypertension: clinical and demographic features. Coll Antropol. 2010;34 Suppl 2:217–21.
Kesler A, Goldhammer Y, Gadoth N. Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuroophthalmol. 2001;21:15–7.
Thurtell MJ, Bruce BB, Rye DB, Newman NJ, Biousse V. The Berlin questionnaire screens for obstructive sleep apnea in idiopathic intracranial hypertension. J Neuroophthalmol. 2011;31:316–9.
Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;60:1418–24.
Arac A, Lee M, Steinberg GK, Marcellus M, Marks MP. Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus. 2009;27:E14.
Bussiere M, Falero R, Nicolle D, Proulx A, Patel V, Pelz D. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2010; 31:645–50.
Donnet A, Metellus P, Levrier O, et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology. 2008; 70:641–7.
Higgins JN, Cousins C, Owler BK, Sarkies N, Pickard JD. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry. 2003;74: 1662–6.
Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology. 1996;46:198–202.
King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology. 1995;45:2224–8.
Ogungbo B, Roy D, Gholkar A, Mendelow AD. Endovascular stenting of the transverse sinus in a patient presenting with benign intracranial hypertension. Br J Neurosurg. 2003;17: 565–8.
Owler BK, Parker G, Halmagyi GM, et al. Cranial venous outflow obstruction and pseudotumor cerebri syndrome. Adv Tech Stand Neurosurg. 2005;30:107–74.
Paquet C, Poupardin M, Boissonnot M, Neau JP, Drouineau J. Efficacy of unilateral stenting in idiopathic intracranial hypertension with bilateral venous sinus stenosis: a case report. Eur Neurol. 2008;60:47–8.
Pickard JD, Czosnyka Z, Czosnyka M, Owler B, Higgins JN. Coupling of sagittal sinus pressure and cerebrospinal fluid pressure in idiopathic intracranial hypertension – a preliminary report. Acta Neurochir Suppl. 2008;102:283–5.
Rajpal S, Niemann DB, Turk AS. Transverse venous sinus stent placement as treatment for benign intracranial hypertension in a young male: case report and review of the literature. J Neurosurg. 2005;102:342–6.
Teleb MS, Rekate H, Chung S, Albuquerque FC. Pseudotumor cerebri presenting with ataxia and hyper-reflexia in a non-obese woman treated with sinus stenting. J Neurointerv Surg. 2012;4:e22.
Zheng H, Zhou M, Zhao B, Zhou D, He L. Pseudotumor cerebri syndrome and giant arachnoid granulation: treatment with venous sinus stenting. J Vasc Interv Radiol. 2010;21: 927–9.
Wall M. Idiopathic intracranial hypertension. Neurol Clin. 1991;9:73–95.
Bulens C, De Vries WA, Van Crevel H. Benign intracranial hypertension. A retrospective and follow-up study. J Neurol Sci. 1979;40:147–57.
Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39:461–74.
Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68:229–32.
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492–5.
Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983;33:1386–8.
Agid R, Farb RI. Neuroimaging in the diagnosis of idiopathic intracranial hypertension. Minerva Med. 2006;97:365–70.
De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci. 2005;25:342–4.
Johnson LN, Krohel GB, Madsen RW, March Jr GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105:2313–7.
Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010; 341:c2701.
Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116: 322–7.
Alsuhaibani AH, Carter KD, Nerad JA, Lee AG. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2011;118:412–4.
Brazis PW. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia. 2008;28:1361–73.
Brazis PW. Surgery for idiopathic intracranial hypertension. J Neuroophthalmol. 2009;29: 271–4.
Ball AK, Howman A, Wheatley K, et al. A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol. 2011;258:874–81.
Fields JD, Javedani PP, Falardeau J, et al. Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension. J Neurointerv Surg. 2013;5(1):62–8.
Albuquerque FC, Dashti SR, Hu YC, et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg. 2011;75:648–52. Discussion 592–5.
Ahmed RM, Wilkinson M, Parker GD, et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol. 2011;32:1408–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chen, Y., Chung, S.M., Haussen, D.C., Yavagal, D.R. (2015). Neurointervention in Ophthalmologic Disorders. In: Edgell, R., Savitz, S., Dalfino, J. (eds) Neurointervention in the Medical Specialties. Current Clinical Neurology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1942-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1942-0_15
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1941-3
Online ISBN: 978-1-4939-1942-0
eBook Packages: MedicineMedicine (R0)